FDA Approves First Alopecia Drug That Restores Hair Growth in Many Patients

The U.S. Food and Drug Administration approved the use of the Janus kinase (JAK) inhibitor baricitinib as a treatment for severe alopecia areata, a disfiguring skin disease. It is the first approved treatment for alopecia areata, an autoimmune disorder that affects about 7 million people in the United States. The often-disfiguring disease, in which the […]

The post FDA Approves First Alopecia Drug That Restores Hair Growth in Many Patients appeared first on Good News Network.

Source: Good News